ISRCTN37373664已完成不适用
A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South Africa
World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)0 个研究点目标入组 285 人开始时间: 2005年11月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 285
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Parents/guardians of subjects who could comply with the protocol requirements (e.g. completion of diary cards, return for follow-up visits)
- •2. Male or female 6 - 10 weeks of age at the time of first vaccination
- •3. Written informed consent from parents/guardians
- •4. Born after a gestation period of 36 - 42 weeks
排除标准
- •1. Use of any investigational or non-registered drug or vaccine other than the study vaccines within 30 days preceding the first dose of study vaccine, or planned use during the study period
- •2. Previous routine vaccination except Bacillus Calmette-Guerin (BCG) and hepatits B virus (HBV)
- •3. Clinically significant history of chronic gastrointestinal tract (GIT) disease including any incorrected congenital malformation of GIT
- •4. History of allergic disease or reaction likely to be exacerbated by any component of the vaccine
- •5. Acute illness at the time of enrolement
- •6. Diarrhoea with in 7 days preceding the study vaccination
- •7. Administration of immunoglobulins and/or blood products since birth or planned during study period
- •8. Use of any investigational or non-registered drug or vaccine other than study vaccines during the study period
研究者
相似试验
进行中（未招募）
1 期
a study of menthol for pain relief during photodynamic therapyActinic keratosis (pre-cancerous sun damage)on the face and scalpMedDRA version: 20.0 Level: PT Classification code 10000614 Term: Actinic keratosis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2015-002849-59-GBniversity of Dundee30
进行中（未招募）
不适用
A double-blind, randomised placebo controlled study of the effects of Acarbose on endothelial function, hemostatic and fibrinolytic plasmatic factors in patients with stable coronary artery disease and either impaired glucose intolerance or newly diagnosed diabetes mellitus1. To study the effect of Acarbose treatment on endothelial function as a potential mechanism for the beneficial effects of better postprandial glycemic control in patients with impaired glucose tolerance or newly diagnosed diabetes mellitusEUCTR2004-002579-17-DEMedizinische Klinik B, Herzzentrum Ludwigshafen
进行中（未招募）
1 期
A double-blind randomised placebo controlled study of cotrimoxazole in the treatment of advanced pulmonary fibrosis - cotrimoazole in advanced fibrotic lung diseaseAdvanced pulmonary fibrosis including common subtypes of usual interstitial pneumonitis and fibrotic non specific pneumonitisEUCTR2006-004927-12-GBSt Helier Hospital NHS Trust140
尚未招募
2 期
Effectiveness of Budesonide in patients with functional dyspepsia.Functional DyspepsiaACTRN12615000150549niversity of Newcastle70
招募中
3 期
The effect of using Growth Hormone in Invitro Fertilisation on livebirth ratesinfertilityACTRN12609001060235Robinson Institute389